149 related articles for article (PubMed ID: 8722708)
41. Neonatal rat pinealocytes: typical and atypical characteristics of [125I]iodohydroxybenzylpindolol binding and adenosine 3',5'-monophosphate accumulation.
Auerbach DA; Klein DC; Woodard C; Aurbach GD
Endocrinology; 1981 Feb; 108(2):559-67. PubMed ID: 6256156
[TBL] [Abstract][Full Text] [Related]
42. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
43. Characterization and localization of vasoactive intestinal peptide receptors in the rat lung.
Leroux P; Vaudry H; Fournier A; St-Pierre S; Pelletier G
Endocrinology; 1984 May; 114(5):1506-12. PubMed ID: 6325122
[TBL] [Abstract][Full Text] [Related]
44. Adrenergic receptors in human liver plasma membranes: predominance of beta 2- and alpha 1-receptor subtypes.
Kawai Y; Powell A; Arinze IJ
J Clin Endocrinol Metab; 1986 May; 62(5):827-32. PubMed ID: 3007555
[TBL] [Abstract][Full Text] [Related]
45. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
Mittag TW; Tormay A; Podos SM
J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
[TBL] [Abstract][Full Text] [Related]
46. Characterization of beta-adrenoceptors in the Syrian hamster Harderian gland: sexual differences and effects of either castration or superior cervical ganglionectomy.
Pangerl A; Pangerl B; Buzzell GR; Jones DJ; Reiter RJ
J Neurosci Res; 1989 Apr; 22(4):456-60. PubMed ID: 2547980
[TBL] [Abstract][Full Text] [Related]
47. Solubilization of active and stable receptors for vasoactive intestinal peptide from rat liver.
Guijarro L; Couvineau A; Calvo JR; Laburthe M
Regul Pept; 1989 Apr; 25(1):37-50. PubMed ID: 2541470
[TBL] [Abstract][Full Text] [Related]
48. Characterization of the beta-adrenergic receptor in isolated human fetal lung type II cells.
Ewing CK; Duffy DM; Roberts JM
Pediatr Res; 1992 Sep; 32(3):350-5. PubMed ID: 1357622
[TBL] [Abstract][Full Text] [Related]
49. Functional receptors for vasoactive intestinal peptide in cultured vascular smooth muscle cells from rat aorta.
Hirata Y; Tomita M; Takata S; Fujita T
Biochem Biophys Res Commun; 1985 Nov; 132(3):1079-87. PubMed ID: 3000363
[TBL] [Abstract][Full Text] [Related]
50. Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation.
Moretti C; Bagnato A; Solan N; Frajese G; Catt KJ
Endocrinology; 1990 Nov; 127(5):2117-26. PubMed ID: 2171907
[TBL] [Abstract][Full Text] [Related]
51. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
Andersson M; Carlquist M; Maletti M; Marie JC
FEBS Lett; 1993 Feb; 318(1):35-40. PubMed ID: 8382169
[TBL] [Abstract][Full Text] [Related]
52. Beta- and alpha-adrenergic receptors are involved in regulating type II thyroxine 5'-deiodinase activity in the rat Harderian gland.
Rubio A; Guerrero JM; Gonzalez MA; López-Gonzalez MA; Osuna C
Life Sci; 1991; 49(21):1523-30. PubMed ID: 1658514
[TBL] [Abstract][Full Text] [Related]
53. Characterization of the vasoactive intestinal peptide receptor in rat submandibular gland: radioligand binding assay in membrane preparations.
Turner JT; Bylund DB
J Pharmacol Exp Ther; 1987 Sep; 242(3):873-81. PubMed ID: 2821229
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
Lanier SM; Hess HJ; Grodski A; Graham RM; Homcy CJ
Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829
[TBL] [Abstract][Full Text] [Related]
55. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
56. Direct demonstration of guanine nucleotide sensitive receptors for vasoactive intestinal peptide in the anterior lobe of the rat pituitary gland.
Agui T; Matsumoto K
Peptides; 1990; 11(3):609-11. PubMed ID: 2166281
[TBL] [Abstract][Full Text] [Related]
57. VIP binding to epithelial cell membranes of rat ventral prostate: effect of guanine nucleotides.
Carmena MJ; Prieto JC
Gen Pharmacol; 1985; 16(5):495-500. PubMed ID: 2996970
[TBL] [Abstract][Full Text] [Related]
58. Binding properties of beta-adrenergic receptors in oviductal smooth muscle membranes.
Kleinstein J
Gynecol Obstet Invest; 1984; 17(5):242-6. PubMed ID: 6329925
[TBL] [Abstract][Full Text] [Related]
59. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.
Pozo D; Montilla ML; Guerrero JM; Calvo JR
Eur J Pharmacol; 1997 Mar; 321(3):379-86. PubMed ID: 9085051
[TBL] [Abstract][Full Text] [Related]
60. Melatonin binding sites in the harderian gland of the rat and Syrian hamster.
Guerrero JM; Menendez-Pelaez A; Calvo JR; Osuna C; Rubio A; Lopez-Gonzalez MA
Biol Signals; 1994; 3(2):99-106. PubMed ID: 7951653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
